Neurovascular Devices – Market Insights – Japan

The Japanese neurovascular device market will see strong growth through 2032. New device launches, increasing adoption of innovative devices backed by favorable clinical data, and rising neurovascular procedures among Japan’s large aging population, as well as the urgent and severe nature of the neurovascular disease treatment procedures, will drive growth in the market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in Japan from 2019 through 2032.

Companies are launching new devices as well as improved versions of existing products to remain competitive in the expanding market.

Which new devices are anticipated to enter the Japanese market within the forecast period, and when are they expected to launch?

Flow-diverting devices are contributing to growth in the embolization device market.

How has the competitive landscape changed with the emergence of new competitors and products?

How will the adoption of flow-diverting devices change the neurovascular embolization coil and coiling-assist device markets?

The thrombectomy device market remains dynamic.

What are the dynamics surrounding the adoption of reperfusion catheters and stent retrievers?

How have the market shares been shifting with the introduction of new products?

The emergence of positive data supporting endovascular intervention will fuel rising demand for neurovascular procedures.

How will results from recent studies impact the uptake of recently launched neurovascular devices?

What other clinical trials have had an impact on uptake of neurovascular devices?

Table of contents